Wells Fargo’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46 Buy
+1
New +$45 ﹤0.01% 6741
2026
Q1
Hold
0
6859
2025
Q4
Sell
-1
Closed -$37 6839
2025
Q3
$30 Hold
1
﹤0.01% 6600
2025
Q2
$28 Buy
+1
New +$35 ﹤0.01% 6699
2025
Q1
Hold
0
6709
2024
Q4
Sell
-1
Closed -$39 6899
2024
Q3
$24 Buy
+1
New +$36 ﹤0.01% 6508
2024
Q2
Sell
-1
Closed -$35 6549
2024
Q1
$28 Hold
1
﹤0.01% 7003
2023
Q4
$33 Hold
1
﹤0.01% 7044
2023
Q3
$30 Buy
+1
New +$32 ﹤0.01% 7062
2023
Q2
Hold
0
7457
2023
Q1
Hold
0
7514

Other funds holding BOUT

Wells Fargo's BOUT Position: Q2 2026 in Review

Wells Fargo opened a new position in CapForce IBD Breakout Opportunities ETF (BOUT) in Q2 2026: 1 share worth $46. The stake represents ﹤0.01% of the portfolio and ranks #6741 among its holdings. This is a return to the name: Wells Fargo previously reported a position in BOUT as recently as Q3 2025.

Wells Fargo first reported a position in BOUT in Q3 2023 and has held it in 7 quarters since. 12 funds tracked by Wall St. Rank hold BOUT as of Q2 2026.

  • Wells Fargo held 1 share of CapForce IBD Breakout Opportunities ETF worth $46 as of Q2 2026.
  • CapForce IBD Breakout Opportunities ETF was a new Wells Fargo position in Q2 2026.
  • CapForce IBD Breakout Opportunities ETF made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6741 holding.
  • Wells Fargo first reported a position in CapForce IBD Breakout Opportunities ETF in Q3 2023 and has held it in 7 quarters since.
  • 12 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.